OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
61 hedge funds and large institutions have $336M invested in Oyster Point Pharma, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
Holders
61
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$13.4M | |
| 2 | +$4.27M | |
| 3 | +$3.51M | |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$939K |
| 5 |
JPMorgan Chase & Co
New York
|
+$879K |
Top Sellers
| 1 | -$5.49M | |
| 2 | -$2.23M | |
| 3 | -$1.18M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$914K |
| 5 |
Millennium Management
New York
|
-$870K |